SEC Form 4 · accession 0001179022-15-000078
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin D Freeman
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 2, 2015 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | P | 2,083 | $2.70 | A | 2,083 | I | IRA |
| Common Stock | holding | — | — | — | 3,917 | D |
Table II — derivative securities
No Table II lines on this filing.